Phospho-PTK2B (Y580) Antibody

What is PTK2B and what is the significance of Y580 phosphorylation?

PTK2B (Protein Tyrosine Kinase 2 Beta), also known as PYK2, FAK2, or RAFTK, is a non-receptor protein-tyrosine kinase that regulates actin cytoskeleton reorganization, cell polarization, migration, adhesion, and spreading. It functions in signaling downstream of multiple receptor types and mediates responses to cellular stress .

The Y580 site is located in the activation loop of the kinase domain. Phosphorylation at this site occurs following autophosphorylation at Y402 and subsequent Src binding. Y580 phosphorylation is crucial for full kinase activation and downstream signaling pathways. Specifically, after Tyr-402 autophosphorylation promotes interaction with SRC family members, this leads to phosphorylation at Tyr-579, Tyr-580, and Tyr-881, with the Y579/Y580 sites being critical for kinase activity .

How does phosphorylation at Y580 relate to PTK2B activation mechanism?

PTK2B activation follows a specific sequence:

• Initial autophosphorylation occurs at Y402, creating a binding site for Src kinases

• Src binding leads to phosphorylation of Y579/Y580 in the activation loop

• Phosphorylation at Y580 is required for full activation of PTK2B kinase activity

This mechanism was demonstrated in studies showing that Pyk2-Src interaction can be monitored through phosphorylation of Y579/Y580. When Pyk2 is first autophosphorylated at Y402 and then exposed to Src, researchers observed rapid phosphorylation at the Y579/Y580 sites . This sequential phosphorylation is essential for proper signal transduction in various cellular processes .

What is the difference between antibodies targeting Y579 and Y580 phosphorylation sites?

While Y579 and Y580 are adjacent phosphorylation sites in PTK2B with similar functions, antibodies targeting these specific sites have distinct recognition patterns:

What are the optimal conditions for using Phospho-PTK2B (Y580) antibody in Western blotting?

For optimal Western blotting results with Phospho-PTK2B (Y580) antibody:

Sample preparation and protocol:

• Use freshly prepared lysates from cells with known PTK2B expression (K562 cells have been validated)

• Recommended dilution range: 1:500-1:2000 for primary antibody incubation

• Buffer system: Standard PBS with 50% glycerol, 0.5% BSA and 0.02% sodium azide

• Control validation: Include both phosphorylated and non-phosphorylated controls

• Expected band size: Approximately 130 kDa

Validation approach:

• Specific band detection can be confirmed by blocking with the phosphopeptide

• For signal specificity confirmation, treat samples with phosphatase to remove phosphorylation

• Include positive controls such as K562 cell lysates, which have been shown to express detectable levels of phosphorylated Y580 PTK2B

How can I optimize immunohistochemistry protocols using Phospho-PTK2B (Y580) antibody?

For immunohistochemistry applications:

Protocol optimization:

• Recommended dilution: 1:100-1:300

• Antigen retrieval: Heat-induced epitope retrieval in citrate buffer (pH 6.0)

• Blocking: 5-10% normal serum from the species of secondary antibody

• Incubation time: Overnight at 4°C for primary antibody

• Detection system: Biotin-streptavidin or polymer-based detection systems

Tissue considerations:

• Brain tissue shows high expression of PTK2B, particularly in amygdala and hippocampus

• Validation should include phosphopeptide blocking controls to confirm specificity

• Consider tissue fixation variables that might affect phosphoepitope preservation

Signal validation:

• Always include a phosphopeptide blocking control alongside the primary antibody

• Use tissues known to express PTK2B (brain sections work well)

• Compare staining patterns with total PTK2B antibody to assess phosphorylation-specific localization

What are key considerations for phospho-specific ELISA using PTK2B (Y580) antibody?

ELISA protocol optimization:

• Recommended antibody dilution: 1:40000

• Blocking buffer: PBS with 1-5% BSA or casein

• Sample preparation: Cell lysates should be prepared with phosphatase inhibitors

• Incubation conditions: 2 hours at room temperature or overnight at 4°C

• Detection system: HRP-conjugated secondary antibody with appropriate substrate

Sensitivity and specificity considerations:

• Perform a standard curve with synthetic phosphopeptides to determine detection limits

• Include non-phosphorylated peptide controls to confirm phospho-specificity

• Consider sandwich ELISA format with capture antibodies against total PTK2B

Data shown in validation studies:
Enzyme-linked immunosorbent assays have demonstrated that the antibody specifically recognizes phosphorylated Y580 peptide with minimal cross-reactivity to non-phosphorylated peptide, as evidenced by comparative ELISA studies showing significantly higher signal with phosphopeptide versus non-phosphopeptide .

How can Phospho-PTK2B (Y580) antibody be utilized in phosphoproteomic studies?

Integration with mass spectrometry:
Phospho-PTK2B (Y580) antibodies can be used in phosphoproteomic workflows to:

• Enrich phosphorylated proteins before MS analysis:

  • Immunoprecipitate phosphorylated PTK2B from complex samples

  • Use as complementary approach alongside TiO2 bead enrichment for comprehensive phosphoproteome coverage

• Validate MS findings:

  • Confirm phosphorylation site identification from large-scale studies

  • Quantify relative abundance of Y580 phosphorylation across experimental conditions

• Targeted analysis:

  • Monitor specific PTK2B phosphorylation in response to stimuli

  • Compare with other phosphorylation sites (Y402, Y579, Y881) to understand activation dynamics

In a tamoxifen resistance breast cancer study, researchers identified 5640 unique phosphopeptides corresponding to 2189 proteins using anti-phosphotyrosine antibody capture followed by MS analysis. This approach successfully characterized phosphorylation patterns in focal adhesion pathways, including PTK2B .

What are the methodological considerations for studying PTK2B activation kinetics using Y580 phosphorylation?

Kinetic assay design:
When studying activation kinetics:

• Time course experiments:

  • Pre-incubate PTK2B (0.5-1.0 μM) in appropriate buffer (e.g., 50 mM HEPES pH 7.4, 150 mM NaCl, 8 mM MgCl₂, 5% glycerol)

  • Initiate reaction with ATP (4 mM final concentration)

  • Quench at specific time points with EDTA (10 mM)

  • Analyze Y580 phosphorylation via Western blotting

• Sequential phosphorylation analysis:

  • Allow autophosphorylation at Y402 (20 minutes pre-incubation)

  • Add Src kinase to monitor subsequent Y579/Y580 phosphorylation

  • Measure phosphorylation by densitometry of Western blots

• Inhibitor studies:

  • Pretreat with specific inhibitors of upstream kinases

  • Monitor effects on Y580 phosphorylation kinetics

  • Compare with other phosphorylation sites to determine sequential relationships

A recent study revealed that Y402 site is conformationally constrained in the autoinhibited state due to beta-sheet formation with the FERM domain. After disruption of this constraint, trans autophosphorylation at Y402 allows Src docking and subsequent activation loop phosphorylation at Y579/Y580 .

How can I investigate PTK2B-Src signaling complexes using Y580 phosphorylation as a readout?

Experimental approach:

• Two-step kinase assay:

  • First stage: Pre-incubate PTK2B (0.5 μM) with ATP (4 mM) for 20 minutes to ensure complete Y402 autophosphorylation

  • Second stage: Add Src kinase and monitor Y579/Y580 phosphorylation over time

  • Sample collection: Quench reactions at various timepoints with EDTA (10 mM)

  • Readout: Western blot with anti-phospho-Y579/Y580 antibody

• Complex formation analysis:

  • Use immunoprecipitation with total PTK2B antibody

  • Probe for co-precipitated Src

  • Correlate complex formation with Y580 phosphorylation status

  • Map interaction domains using truncation mutants

• Conformational probe approach:

  • Utilize molecularly imprinted nanoparticles (MINPs) as conformational probes

  • Test effects of MINPs targeting specific PTK2B regions on Y580 phosphorylation

  • Compare effects of different MINPs (e.g., MINP(pY402) vs. MINP(PRR))

Research has demonstrated that MINPs can serve as effective conformational probes to investigate the PTK2B-Src interaction, revealing that Y402 phosphorylation creates a docking site for Src, which then phosphorylates the Y579/Y580 sites in the activation loop .

What are common issues in detecting phospho-PTK2B (Y580) and how can they be addressed?

Common challenges and solutions:

Validation strategies:

• Always include positive control (K562 cells show good phospho-Y580 signal)

• Run parallel blots with total PTK2B antibody to confirm protein expression

• Include phosphopeptide blocking controls to demonstrate specificity

• Consider phosphatase treatment of duplicate samples as negative controls

How can I ensure phospho-epitope preservation during sample preparation?

Best practices for phospho-epitope preservation:

• Cell/tissue harvest:

  • Rapid sample processing is critical

  • Consider in situ fixation before harvesting cells/tissues

  • Stimulated samples should be processed immediately after treatment

• Lysis buffer formulation:

  • Include multiple phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate)

  • Use fresh inhibitors for each experiment

  • Maintain cold temperature (4°C) throughout processing

  • Buffer composition: 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate with phosphatase inhibitor cocktail

• Storage considerations:

  • Store samples at -80°C with aliquoting to avoid freeze-thaw cycles

  • For long-term storage, consider adding 10% glycerol to prevent protein denaturation

  • Always re-add phosphatase inhibitors when diluting stored samples

• Tissue-specific considerations:

  • Brain tissue (high PTK2B expression) requires particularly careful handling

  • Flash-freezing in liquid nitrogen immediately after collection

  • Consider phosphatase activity differences between tissue types when optimizing protocols

What controls should be included when using phospho-PTK2B (Y580) antibody in different applications?

Essential controls for rigorous experimental design:

Quantification standards:

• For Western blot, normalize phospho-signal to total PTK2B or housekeeping protein

• In kinase assays, include time-course samples for kinetic analysis

• For ELISA, prepare standard curves with synthetic phosphopeptides

• In imaging applications, include calibration samples with known phosphorylation levels

How does PTK2B Y580 phosphorylation contribute to cancer signaling pathways?

Role in cancer biology:

Phosphorylation at Y580 of PTK2B plays critical roles in cancer signaling networks:

• Focal adhesion signaling:

  • Y580 phosphorylation is required for full activation of PTK2B in focal adhesion complexes

  • Activated PTK2B promotes cell migration, invasion, and metastatic potential

  • Phosphoproteome analyses have identified focal adhesion pathways as significantly enriched in tamoxifen-resistant breast cancer cells

• Integration with oncogenic pathways:

  • Activated PTK2B (phosphorylated at Y580) promotes downstream activation of:

    • PI3K/AKT signaling pathway

    • MAP kinase cascade (MAPK1/ERK2, MAPK3/ERK1, MAPK8/JNK1)

    • Rho family GTPases (RHOA, RAC1)

  • These pathways collectively contribute to cancer cell survival, proliferation, and therapy resistance

• Therapeutic implications:

  • Monitoring Y580 phosphorylation could serve as a biomarker for cancer progression

  • Inhibiting the phosphorylation cascade leading to Y580 phosphorylation represents a potential therapeutic strategy

  • Understanding the unique role of Y580 versus other phosphorylation sites could inform more specific therapeutic approaches

What are emerging techniques for studying spatiotemporal dynamics of PTK2B Y580 phosphorylation?

Cutting-edge methodological approaches:

• Live-cell imaging technologies:

  • FRET-based biosensors to monitor Y580 phosphorylation in real-time

  • Development of conformation-specific nanobodies that recognize phosphorylated Y580

  • Correlative light-electron microscopy to relate phosphorylation status to ultrastructural features

• New chemical biology tools:

  • Molecularly imprinted nanoparticles (MINPs) as conformational probes

  • Studies have used MINPs to investigate Pyk2-Src interactions and subsequent Y579/Y580 phosphorylation

  • These tools allow manipulation of specific conformational states of PTK2B

• Single-molecule techniques:

  • Super-resolution microscopy to visualize individual phosphorylated PTK2B molecules

  • Single-molecule pull-down assays to analyze complex formation dependent on Y580 phosphorylation

  • Correlating PTK2B movement and phosphorylation status in living cells

Recent research has demonstrated that MINPs can reveal new insights into PTK2B regulation, showing that Y402 site is conformationally constrained in the autoinhibited state, and its release leads to autophosphorylation followed by Src-mediated Y579/Y580 phosphorylation .

How can phospho-PTK2B (Y580) antibodies contribute to studying neurodegenerative diseases?

Neurological research applications:

• PTK2B in neurodegeneration:

  • PTK2B is most abundant in the brain, particularly in amygdala and hippocampus

  • Phosphorylation at Y580 regulates PTK2B activity in neuronal signaling pathways

  • Altered PTK2B phosphorylation has been implicated in neurodegeneration

• Methodological approaches:

  • Brain-specific tissue processing protocols to preserve phospho-epitopes

  • Optimization of IHC protocols for brain tissue sections (1:100-1:300 dilution)

  • Co-labeling with neuronal markers to identify cell type-specific phosphorylation patterns

• Experimental models:

  • Primary neuronal cultures for studying activity-dependent PTK2B phosphorylation

  • Brain slice preparations for maintaining tissue architecture

  • Animal models of neurodegenerative diseases to track PTK2B phosphorylation changes

• Therapeutic implications:

  • Monitoring Y580 phosphorylation as a biomarker for neuronal stress

  • Targeting PTK2B phosphorylation pathways for neuroprotection

  • Understanding signaling mechanisms that regulate PTK2B in neurons could reveal new therapeutic targets

What are the best practices for quantifying phospho-PTK2B (Y580) signals in diverse experimental setups?

Quantification strategies:

How should I interpret differential phosphorylation patterns between Y402 and Y580 sites in PTK2B?

Mechanistic interpretation framework:

• Sequential phosphorylation model:

  • Y402 is the primary autophosphorylation site

  • Y402 phosphorylation creates docking site for Src kinases

  • Src binding leads to phosphorylation at Y579/Y580

  • Differential phosphorylation between sites reflects progression through activation sequence

• Interpretation guidelines:

  • High pY402 with low pY580: Initial activation stage (Src recruitment not yet complete)

  • High pY402 and high pY580: Full activation stage (complete Src-mediated phosphorylation)

  • Low pY402 with high pY580: Rare; might indicate alternative activation mechanisms

  • Changes in pY402:pY580 ratio can reveal rate-limiting steps in activation

• Experimental approach:

  • Monitor both sites in time-course experiments

  • Use Src inhibitors to block progression from pY402 to pY580

  • Compare wild-type with Y402F mutants to confirm dependency

• Cellular context considerations:

  • Different cell types may show varying relationships between these phosphorylation sites

  • Stimulus-specific responses might alter the typical phosphorylation sequence

  • Consider subcellular localization differences between differently phosphorylated forms

Research has demonstrated that conformational changes in PTK2B regulate this sequential phosphorylation, with Y402 site being conformationally constrained in the autoinhibited state due to beta-sheet formation with the FERM domain .

What statistical approaches are appropriate for analyzing phosphorylation changes across experimental conditions?

Statistical analysis workflow:

• Experimental design considerations:

  • Power analysis to determine appropriate sample size

  • Include biological replicates (n≥3) for robust statistical analysis

  • Consider technical replicates to account for assay variability

  • Design appropriate controls for normalization

• Normalization approaches:

  • For Western blots: Normalize to total PTK2B or housekeeping proteins

  • For mass spectrometry: Normalize to non-phosphorylated peptides or global intensity

  • For imaging: Use internal reference standards or control regions

• Statistical tests for phosphorylation data:

  • For comparing two conditions: Student's t-test or Mann-Whitney U test (non-parametric)

  • For multiple conditions: ANOVA with appropriate post-hoc tests (Tukey, Dunnett)

  • For time-course data: Repeated measures ANOVA or mixed-effects models

  • For correlation analysis: Pearson or Spearman correlation coefficients

• Advanced analytical approaches:

  • For phosphoproteomics: Consider specialized software (MaxQuant, Perseus)

  • For pathway analysis: Gene set enrichment analysis of phosphorylation patterns

  • For kinetic data: Fit appropriate models (Michaelis-Menten, exponential)

  • Set appropriate thresholds for significance (typically twofold change for hyperphosphorylation and 0.5-fold for hypophosphorylation, with p<0.05)